Healthcare -
Biotechnology - NASDAQ - US
$ 10.86
3.23 %
$ 440 M
Market Cap
-2.08
P/E
KROS - OPERATING EXPENSES
Operating Expenses KROS - Keros Therapeutics, Inc.
170 M
LAST VALUE
49.14%
2 YEAR CAGR
71.93%
5 YEAR CAGR
0.00%
10 YEAR CAGR